Article Information
PubMed
Print ISSN
Online ISSN
History
- Received July 24, 2012
- Accepted November 1, 2012
- Published online December 20, 2012.
Article Versions
- Earlier version (November 1, 2012 - 11:04).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2013 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Zhengping Wang,
- Jinfu Yang,
- Christopher Kirk,
- Ying Fang,
- Melissa Alsina,
- Ashraf Badros,
- Kyriakos Papadopoulos,
- Alvin Wong,
- Tina Woo,
- Darrin Bomba,
- Jin Li, and
- Jeffrey R. Infante
- Onyx Pharmaceuticals, South San Francisco, California (Z.W., J.Y., C.K., Y.F., A.W., T.W., D.B., J.L.); H. Lee Moffitt Cancer and Research Center, Tampa, Florida (M.A.); Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland (A.B.); The START (South Texas Accelerated Research Therapeutics) Center for Cancer Care, San Antonio, Texas (K.P.); and Sarah Cannon Research Institute, Nashville, Tennessee (J.R.I.)
- Address correspondence to:
Dr. Jinfu Yang, Onyx Pharmaceuticals, 249 E. Grand Ave., South San Francisco, CA 94080. E-mail: yangjinfu{at}yahoo.com
J.Y. and Z.W. contributed equally to this work.
This work was partially presented in abstract form as follows: Zhengping Wang, Jinfu Yang, Ying Fang, Frances Zhao, Marcy Valone, Darrin Bomba, Alvin Wong and Christopher Kirk. (2011) In vitro and In vivo Drug-drug Interaction Studies of Carfilzomib. American Association of Pharmaceutical Scientists, Annual Meeting and Exposition (2011) (Abstract #: T2419) Oct 23–27; Washington, DC.